| 生物活性 | |||
|---|---|---|---|
| 靶点 | 
 | ||
| 描述 | BMY 7378 Dihydrochloride is a multi-target inhibitor, which acts on α 2C and α 1D adrenoceptors, with PKI of 6.54 and 8.2, respectively. It is a mixed 5-HT1A receptor agonist and antagonist, with PKI of 8.3[3]. In vitro research suggests that BMY 7378 Dihydrochloride has a PKI value 6.06±0.09 in AC01 cells[4]. In vivo , BMY 7378 Dihydrochloride dose-dependently (0.25-5 mg/kg) decreased 8-OH-DPAT (0.75 mg/kg)-induced unmeasured level of forepaw stampede and head shaking in rats. In the ventral hippocampus of anesthetized rats, BMY 7378 Dihydrochloride significantly reduced the release of 5-HT in a dose-dependent manner by microdialysis[5]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.18mL 0.44mL 0.22mL | 10.91mL 2.18mL 1.09mL | 21.81mL 4.36mL 2.18mL | 
| 参考文献 | 
|---|
| [1]Cleary L, et al. Auton Autacoid Pharmacol, 2005, 25(4), 135-141. |